First Time Loading...

Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 73.26 USD 0.48% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. [ Read More ]

The intrinsic value of one BSX stock under the Base Case scenario is 52.78 USD. Compared to the current market price of 73.26 USD, Boston Scientific Corp is Overvalued by 28%.

Key Points:
BSX Intrinsic Value
Base Case
52.78 USD
Overvaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Boston Scientific Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BSX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Boston Scientific Corp

Provide an overview of the primary business activities
of Boston Scientific Corp.

What unique competitive advantages
does Boston Scientific Corp hold over its rivals?

What risks and challenges
does Boston Scientific Corp face in the near future?

Has there been any significant insider trading activity
in Boston Scientific Corp recently?

Summarize the latest earnings call
of Boston Scientific Corp.

What significant events have occurred
in Boston Scientific Corp over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Boston Scientific Corp.

Provide P/S
for Boston Scientific Corp.

Provide P/E
for Boston Scientific Corp.

Provide P/OCF
for Boston Scientific Corp.

Provide P/FCFE
for Boston Scientific Corp.

Provide P/B
for Boston Scientific Corp.

Provide EV/S
for Boston Scientific Corp.

Provide EV/GP
for Boston Scientific Corp.

Provide EV/EBITDA
for Boston Scientific Corp.

Provide EV/EBIT
for Boston Scientific Corp.

Provide EV/OCF
for Boston Scientific Corp.

Provide EV/FCFF
for Boston Scientific Corp.

Provide EV/IC
for Boston Scientific Corp.

Show me price targets
for Boston Scientific Corp made by professional analysts.

What are the Revenue projections
for Boston Scientific Corp?

How accurate were the past Revenue estimates
for Boston Scientific Corp?

What are the Net Income projections
for Boston Scientific Corp?

How accurate were the past Net Income estimates
for Boston Scientific Corp?

What are the EPS projections
for Boston Scientific Corp?

How accurate were the past EPS estimates
for Boston Scientific Corp?

What are the EBIT projections
for Boston Scientific Corp?

How accurate were the past EBIT estimates
for Boston Scientific Corp?

Compare the revenue forecasts
for Boston Scientific Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Boston Scientific Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Boston Scientific Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Boston Scientific Corp compared to its peers.

Compare the P/E ratios
of Boston Scientific Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Boston Scientific Corp with its peers.

Analyze the financial leverage
of Boston Scientific Corp compared to its main competitors.

Show all profitability ratios
for Boston Scientific Corp.

Provide ROE
for Boston Scientific Corp.

Provide ROA
for Boston Scientific Corp.

Provide ROIC
for Boston Scientific Corp.

Provide ROCE
for Boston Scientific Corp.

Provide Gross Margin
for Boston Scientific Corp.

Provide Operating Margin
for Boston Scientific Corp.

Provide Net Margin
for Boston Scientific Corp.

Provide FCF Margin
for Boston Scientific Corp.

Show all solvency ratios
for Boston Scientific Corp.

Provide D/E Ratio
for Boston Scientific Corp.

Provide D/A Ratio
for Boston Scientific Corp.

Provide Interest Coverage Ratio
for Boston Scientific Corp.

Provide Altman Z-Score Ratio
for Boston Scientific Corp.

Provide Quick Ratio
for Boston Scientific Corp.

Provide Current Ratio
for Boston Scientific Corp.

Provide Cash Ratio
for Boston Scientific Corp.

What is the historical Revenue growth
over the last 5 years for Boston Scientific Corp?

What is the historical Net Income growth
over the last 5 years for Boston Scientific Corp?

What is the current Free Cash Flow
of Boston Scientific Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Boston Scientific Corp.

Financials

Balance Sheet Decomposition
Boston Scientific Corp

Current Assets 6.5B
Cash & Short-Term Investments 865m
Receivables 2.2B
Other Current Assets 3.4B
Non-Current Assets 28.6B
Long-Term Investments 413m
PP&E 3.3B
Intangibles 20.4B
Other Non-Current Assets 4.5B
Current Liabilities 4.9B
Accounts Payable 942m
Accrued Liabilities 2.5B
Other Current Liabilities 1.5B
Non-Current Liabilities 10.9B
Long-Term Debt 8.6B
Other Non-Current Liabilities 2.4B
Efficiency

Earnings Waterfall
Boston Scientific Corp

Revenue
14.2B USD
Cost of Revenue
-4.3B USD
Gross Profit
9.9B USD
Operating Expenses
-7.5B USD
Operating Income
2.4B USD
Other Expenses
-858m USD
Net Income
1.6B USD

Free Cash Flow Analysis
Boston Scientific Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

BSX Profitability Score
Profitability Due Diligence

Boston Scientific Corp's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
ROE is Increasing
55/100
Profitability
Score

Boston Scientific Corp's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

BSX Solvency Score
Solvency Due Diligence

Boston Scientific Corp's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
55/100
Solvency
Score

Boston Scientific Corp's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BSX Price Targets Summary
Boston Scientific Corp

Wall Street analysts forecast BSX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BSX is 74.98 USD with a low forecast of 63.63 USD and a high forecast of 85.05 USD.

Lowest
Price Target
63.63 USD
13% Downside
Average
Price Target
74.98 USD
2% Upside
Highest
Price Target
85.05 USD
16% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

BSX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

BSX Price
Boston Scientific Corp

1M 1M
+8%
6M 6M
+47%
1Y 1Y
+43%
3Y 3Y
+73%
5Y 5Y
+96%
10Y 10Y
+439%
Annual Price Range
73.26
52w Low
48.64
52w High
73.26
Price Metrics
Average Annual Return 7.01%
Standard Deviation of Annual Returns 20.73%
Max Drawdown -43%
Shares Statistics
Market Capitalization 107.4B USD
Shares Outstanding 1 476 900 000
Percentage of Shares Shorted 0.85%

BSX Return Decomposition
Main factors of price return

What is price return decomposition?

BSX News

Other Videos

Last Important Events
Boston Scientific Corp

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Boston Scientific Corp

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Boston Scientific Corp Logo
Boston Scientific Corp

Country

United States of America

Industry

Health Care

Market Cap

107.4B USD

Dividend Yield

0%

Description

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. The company is headquartered in Marlborough, Massachusetts and currently employs 41,000 full-time employees. The Company’s business segments include MedSurg, Rhythm and Neuro, and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Pelvic Health. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal (GI) and pulmonary conditions. Its Urology and Pelvic Health business develops and manufactures devices to treat various urological and pelvic conditions. The Rhythm and Neuro segment include Cardiac Rhythm Management (CRM) and Electrophysiology. Its CRM develops and manufactures a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment include Interventional Cardiology and Peripheral Interventions. Its Interventional Cardiology develops and manufactures technologies for diagnosing and treating coronary artery disease and structural heart conditions.

Contact

MASSACHUSETTS
Marlborough
300 Boston Scientific Way
+15086834000.0
https://www.bostonscientific.com/

IPO

1992-05-19

Employees

41 000

Officers

Chairman, President & CEO
Mr. Michael F. Mahoney
Executive VP & CFO
Mr. Daniel J. Brennan
Executive VP & Group President of Cardiology
Mr. Joseph M. Fitzgerald
Executive VP & President of Peripheral Interventions
Mr. Jeffrey B. Mirviss
Executive VP and Group President of MedSurg & Asia Pacific
Mr. Arthur Crosswell Butcher
Independent Director
Mr. David J. Roux
Show More
Executive Vice President of Global Operations
Mr. John Bradley Sorenson
Senior VP, Global Controller & Chief Accounting Officer
Ms. Emily Woodworth
Senior VP and Chief Information & Digital Officer
Ms. Jodi Euerle Eddy
Senior VP of Investor Relations
Mr. Jonathan R Monson
Show Less

See Also

Discover More
What is the Intrinsic Value of one BSX stock?

The intrinsic value of one BSX stock under the Base Case scenario is 52.78 USD.

Is BSX stock undervalued or overvalued?

Compared to the current market price of 73.26 USD, Boston Scientific Corp is Overvalued by 28%.